Suzanne M. Hanlon Zynerba Pharmaceuticals, Inc. (ZYNE) insider trading activity

ZYNE Quotes by TradingView

Suzanne M. Hanlon is Sec, VP & General Counsel of Zynerba Pharmaceuticals, Inc.. Currently has a direct ownership of 80,693 shares of ZYNE, which is worth approximately $0. The most recent transaction as insider was on Jan 21, 2021, when has been sold 37,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 80.7K
0% 3M change
0% 12M change
Total Value Held $0

Suzanne M. Hanlon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 21 2021
BUY
Grant, award, or other acquisition
-
37,000 Added 31.44%
80,693 Common Stock
SMH

Suzanne M. Hanlon

Sec, VP & General Counsel
Devon, PA

Track Institutional and Insider Activities on ZYNE

Follow Zynerba Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZYNE shares.

Notify only if

Insider Trading

Get notified when an Zynerba Pharmaceuticals, Inc. insider buys or sells ZYNE shares.

Notify only if

News

Receive news related to Zynerba Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ZYNE